New MLT-based therapeutic developments



Lipopharma currently investigates the therapeutic applications of new compounds based on our innovative Membrane Lipid Content Modification approach.


LP30171 is a new MLT-based fatty acid derivative currently being investigated as a potential treatment for cancer and metabolic disorders.


© 2019 Lipopharma | legal notice Copyright 2011 Lipopharma - New LP series. All Rights Reserved.
Joomla 1.7 templates by hostgator coupon and learn how to make a website